Critical Care & Emergencies (all articles)
Review: Infective endocarditis after surgical and transcatheter aortic valve replacement
19 Aug, 2020 | 09:23h | UTC
SARS-CoV-2 transmission in a community setting before and after the use of face shields
18 Aug, 2020 | 07:51h | UTC
Study suggests low risk of post-discharge venous thromboembolism following hospital admission with COVID-19
16 Aug, 2020 | 22:24h | UTCPost-discharge venous thromboembolism following hospital admission with COVID-19 – Blood
Commentary: Post-Hospital Venous Thromboembolism in Patients With COVID-19 – American College of Cardiology
Clinical update: Influenza in the COVID-19 era
16 Aug, 2020 | 22:31h | UTCInfluenza in the COVID-19 Era – JAMA
Commentary on Twitter
Despite the rapid pace of progress in the areas of #SARSCoV2 diagnostics, treatment, and vaccine development, the population remains vulnerable to concurrent influenza and #COVID19 epidemics https://t.co/414veJwuYj
— JAMA (@JAMA_current) August 14, 2020
Cohort study: ECMO for severe acute respiratory distress syndrome associated with COVID-19
16 Aug, 2020 | 22:28h | UTCInvited Commentary: ECMO for severe ARDS associated with COVID-19: now we know we can, but should we? – The Lancet Respiratory Medicine
Commentary on Twitter
Our approaches and treatments for severe #COVID19 keep getting better. Use of blood thinners, dexamethasone, when to use mechanical ventilation, etc. We're also getting smarter about the use of ECMO@LancetRespirMed https://t.co/LXfZnVaEJ8@JAMASurgery https://t.co/Osmjne9btb pic.twitter.com/Pq1u6TMNV8
— Eric Topol (@EricTopol) August 14, 2020
Diagnosing COVID‐19 in the ED: A scoping review of clinical examinations, laboratory tests, imaging accuracy, and biases
16 Aug, 2020 | 22:23h | UTC
Randomized trial: Imipenem/Cilastatin/Relebactam vs. Piperacillin/Tazobactam in adults with hospital-acquired or ventilator-associated bacterial pneumonia
16 Aug, 2020 | 22:12h | UTC
Randomized trial: Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19
14 Aug, 2020 | 01:53h | UTCRelated Study: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report – New England Journal of Medicine
Commentary on Twitter
Metcovid Double Blind PH. 2
RCT 🇧🇷~ 400 pts #CID
Methylprednisolon 0.5mg/kg twice daily x5d #COVID19 Hospitalized pts #COVID19 did not reduce 28d mortality V placebo
Is it Right Drug, Dose, Duration
High dose vs RECOVERY
DEX less mineralocorticoid
5 v 10 https://t.co/EBIRWYouSQ pic.twitter.com/OzGJkqjkrJ— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) August 13, 2020
Coagulopathy in COVID-19: Manifestations and management
14 Aug, 2020 | 01:21h | UTCCoagulopathy in COVID-19: Manifestations and management – Cleveland Clinic Journal of Medicine
[Preprint] Observational study: Effect of convalescent plasma on mortality among hospitalized patients with COVID-19
14 Aug, 2020 | 01:24h | UTCCommentary: Large study suggests convalescent plasma can help treat Covid-19, but experts have doubts – STAT
Commentary on Twitter
🔥 Preliminary results from convalescent plasma Expanded Access Program 🔥
35,322 patients 😯
Not an RCT 😞
But, lower mortality with earlier administration & higher antibody titre support possible efficacy 🧐https://t.co/xwzz3mQ0qX pic.twitter.com/Utquky4wW1
— Ilan Schwartz is on🦋 (@GermHunterMD) August 13, 2020
Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19
14 Aug, 2020 | 01:17h | UTCCommentary: New prediction model can forecast personalized risk for COVID-19-related hospitalization – MedicalXpress
Online risk calculator: Predict Hospitalization Risk for COVID-19 Positive
Randomized trial: AVIFAVIR for Treatment of Patients with Moderate COVID-19
13 Aug, 2020 | 00:28h | UTC
Commentary on Twitter
NEW 🔥🔥 #CID @IDSAInfo
AVIFAVIR(favipiravir) for Treatment of Patients with Moderate #COVID19 : Interim Results of a Phase II/III Multicenter Randomized Clinical Trial #IDTwitter https://t.co/PwUcCWu5KQ pic.twitter.com/6N6lxHUu9K— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) August 8, 2020
ECMO for patients with COVID-19 in severe respiratory failure
13 Aug, 2020 | 00:23h | UTC
Meta-analysis: Laboratory features of severe vs. non-severe COVID-19 patients
13 Aug, 2020 | 00:26h | UTC
[Preprint] Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients
13 Aug, 2020 | 00:18h | UTCViable SARS-CoV-2 in the air of a hospital room with COVID-19 patients – medRxiv
Commentaries: Viable SARS-CoV-2 aerosols detected in a hospital room with COVID-19 patients – News Medical AND ‘A Smoking Gun’: Infectious Coronavirus Retrieved From Hospital Air – The New York Times
Diagnostic performance of Chest CT for SARS-CoV-2 infection in individuals with or without COVID-19 symptoms
13 Aug, 2020 | 00:22h | UTC
Pseudotumor cerebri syndrome associated with MIS-C/Covid-19: a case report
13 Aug, 2020 | 00:06h | UTCPseudotumor cerebri syndrome associated with MIS-C: a case report – The Lancet
Commentary on Twitter
First report of pseudotumor cerebri, a potentially vision-threatening condition, in a 14-year-old-girl w/ #COVID19 and MIS-C.
Bilateral papilledema, ⬆️intracranial pressure, disc hemorrhages, eye palsyhttps://t.co/xCGuXm9JVf @TheLancet @LanaVerkuil @PennMedicine @ChildrensPhila pic.twitter.com/anrGqdNXjN— Eric Topol (@EricTopol) August 11, 2020
Pictorial essay: Neurological emergencies associated with COVID-19: stroke and beyond
13 Aug, 2020 | 00:07h | UTCNeurological emergencies associated with COVID-19: stroke and beyond – Emergency Radiology
Randomized trial: No benefit from combination therapy of vitamin C and thiamine for septic shock
13 Aug, 2020 | 00:01h | UTC
Podcast: Updated pulmonary embolism guidelines
12 Aug, 2020 | 23:57h | UTCUpdated Pulmonary Embolism Guidelines – JAMA
Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit?
12 Aug, 2020 | 02:38h | UTCAntibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit? – Nature
Related: Antibody drugs could be one of the best weapons against Covid-19. But will they matter? – STAT AND Designer antibodies could battle COVID-19 before vaccines arrive – Science
A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic
12 Aug, 2020 | 02:23h | UTC
Risk to health from COVID‐19 for anesthetists and intensivists – a narrative review
12 Aug, 2020 | 02:22h | UTCRisk to health from COVID‐19 for anaesthetists and intensivists – a narrative review – Anaesthesia
Managing hyperglycemia in the COVID-19 inflammatory storm
12 Aug, 2020 | 02:24h | UTCManaging Hyperglycemia in the COVID-19 Inflammatory Storm – Diabetes
COncise adVice on Inpatient Diabetes (COVID:Diabetes)
11 Aug, 2020 | 10:30h | UTCCOncise adVice on Inpatient Diabetes (COVID:Diabetes) – Diabetes UK
Commentary: Guidance Covers Glycemia in Dexamethasone-Treated COVID-19 – Medscape (free registration required)